Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
Investigation of nanoparticulate platforms for transdermal delivery of Tolvaptan
- At: Seville (Spain) (2022)
- Type: Poster
- Poster code: DDD-018
- By: MANIKKATH, Jyothsna (Manipal College of Pharmaceutical Sciences, Manipal Academy Of Higher Education, India)
- Co-author(s): Dr Jyothsna Manikkath, Assistant Professor (Manipal College of Pharmaceutical Sciences, Manipal Academy Of Higher Education, Manipal, India)
Mr M Resvanulla
Background information: Tolvaptan is an orally administered BCS class IV agent used for vasopressin antagonism in congestive heart failure. Its low solubility and permeability present issues such as variation in gastrointestinal absorption, food effect, low bioavailability and poor compliance.
Purpose: The objective of this work was to develop.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Last update 4 October 2019